Answers are grounded in this paper and cite their sources.
Primary pulmonary lymphoma is rare, and pulmonary tuberculosis (TB) can closely resemble lymphoma on 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT). We report the case of a 90-year-old man with biopsy-proven primary pulmonary diffuse large B-cell lymphoma, germinal center B-cell type. Baseline PET/CT demonstrated hypermetabolic pulmonary nodules with a maximum standardized uptake value of 6.4. After six cycles of R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone), restaging PET/CT showed increased lesion size and FDG uptake, corresponding to a Deauville score of 5 and initially raising concern for refractory lymphoma. However, repeat biopsy of a metabolically active pulmonary lesion revealed necrotizing granulomatous inflammation with acid-fast bacilli, supporting active pulmonary TB. Anti-TB treatment was initiated. This case illustrates an important diagnostic pitfall: progressive FDG uptake after chemotherapy should not automatically be interpreted as treatment failure, particularly in TB-endemic settings or immunosuppressed patients. When imaging findings are discordant with the clinical context, repeat tissue confirmation should be strongly considered before escalating lymphoma therapy.
No takes yet. Share an insight, caveat, or question.
Thinh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: